Bunkyo-ku, Japan

Hideaki Tahara

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 88(Granted Patents)


Location History:

  • Meguro-ku, JP (2008 - 2013)
  • Tokyo, JP (2002 - 2014)
  • Bunkyo-ku, JP (2011 - 2016)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: **The Innovative Contributions of Hideaki Tahara**

Introduction

Hideaki Tahara, based in Bunkyo-ku, Japan, is an accomplished inventor renowned for his contributions to the field of cancer therapy. With a remarkable portfolio of 17 patents, his innovative work focuses on developing effective treatments that leverage oncolytic viruses and antibodies to combat cancer.

Latest Patents

Among his latest patents, one noteworthy innovation is the development of an oncolytic virus specifically designed for cancer therapy. This invention aims to create a virus preparation comprising an oncolytic herpes simplex virus (HSV) that demonstrates enhanced cancer cell-killing activity, surpassing existing HSV therapies. This preparation includes an HSV with a receptor-retargeted gD mutation and a genome that features a membrane fusion activity-promoting region. Another significant patent is for an anti-cancer drug that utilizes an anti-MFG-E8 antibody as its active ingredient. This drug can also be combined with other anti-cancer agents, showcasing adaptability in cancer treatment methodologies that could influence future therapeutic approaches.

Career Highlights

Hideaki Tahara has made substantial strides in his career, having worked with reputable organizations such as Oncotherapy Science Incorporated and The University of Tokyo. His tenure at these institutions has allowed him to merge his innovative ideas with research excellence, fostering advancements in cancer therapies.

Collaborations

Throughout his career, Tahara has collaborated with esteemed professionals, including Takuya Tsunoda and Satoshi Wada. These partnerships have been instrumental in furthering his research efforts and driving innovation in the medical field.

Conclusion

Hideaki Tahara continues to be a significant figure in the realm of cancer research and treatment innovation. His commitment to developing groundbreaking therapies places him at the forefront of the fight against cancer, and his patents underscore the potential to improve patient outcomes through novel scientific approaches. As he advances his research, the impact of his work is likely to resonate throughout the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…